Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126399731 | 12639973 | 1 | I | 20160805 | 20160810 | 20160810 | EXP | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-52063BI | BOEHRINGER INGELHEIM | CHIM C,DIMITROPOULOS E,GINZBURG R. IMPLEMENTING A POLICY AND PROTOCOL ON MANAGING PATIENTS WITH HYPERTENSIVE URGENCIES. ANNALS OF PHARMACOTHERAPY 2016;50:7:548-554. | 0.00 | Y | 0.00000 | 20160810 | OT | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126399731 | 12639973 | 1 | PS | CATAPRES | CLONIDINE HYDROCHLORIDE | 1 | Unknown | U | 17407 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126399731 | 12639973 | 1 | Hypertensive crisis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126399731 | 12639973 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126399731 | 12639973 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |